community cancer clinic to determine if variation in regimens ordered was impacted by implementing the CDS tool. Methods: This study used the nationwide EHR-derived de-identified Flatiron Health database to analyze treatment regimens ordered for Breast
Search Results
QIM23-132: Do EHR-Embedded Clinical Decision Support Tools Reduce Variation in Care? A Pre and Post-Implementation Comparison of Regimen Ordering Variation at a Multi-Site Community Cancer Clinic
Jonas M. Congelli, Heather Lewin, Gregory Calip, Marcello Ricottone, Shawn Huda, Taylor Dias-Foundas, and Rebecca Maniago
CLO23-032: Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
Dariusz Uczkowski, Arunabh Sekhri, Shilpi Gupta, Leah Gendler, Krzysztof Misiukiewicz, Miles Levin, and Bonni Guerin
. Conclusion: In a community hospital setting, retained HER2 positivity on RD after NAC was associated with a statistically worse RFS. Although, small sample size and short follow-up time likely contributed to this outcome and further prospective investigation
HSR21-070: Feasibility of Tracking Digital Activity, Sleep, and Patient-Reported Outcomes (PROs) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Undergoing an In-Class Transition From Parenteral Bortezomib-Based Therapy to Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) in the Ongoing Community-Based United States (US) MM-6 Study (NCT03173092)
Kirsten Stuber, Habte A. Yimer, Karin Choquette, Sudhir Manda, Jennifer Clayton, Saulius Girnius, Joshua Richter, Presley Whidden, Kimberly Bogard, Dasha Cherepanov, and Stephen J. Noga
Background: US MM-6 is evaluating in-class transition from parenteral bortezomib-based induction to all-oral IRd in US community NDMM pts, with the aim of increasing proteasome-inhibitor-based treatment duration while maintaining quality of life
Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool
Gabrielle B. Rocque, Richard A. Taylor, Aras Acemgil, Xuelin Li, Maria Pisu, Kelly Kenzik, Bradford E. Jackson, Karina I. Halilova, Wendy Demark-Wahnefried, Karen Meneses, Yufeng Li, Michelle Y. Martin, Carol Chambless, Nedra Lisovicz, Mona Fouad, Edward E. Partridge, Elizabeth A. Kvale, and the Patient Care Connect Group
on screening of geriatric patients in rural, community settings. In addition, the sources of distress for this patient population have not been characterized. Patient navigators may be able to both screen for and mitigate sources of distress for
QIM20-124: Retrospective Evaluation of VEGF Inhibitor-Associated Hypertension at a Community Cancer Center
Jasmin Eugene, Carli Nesheiwat, and Scott Overmier
Improving Health Equity and Reducing Disparities in Pediatric and Adolescent/Young Adult Oncology: In Support of Clinical Practice Guidelines
Justine M. Kahn and Melissa Beauchemin
categorized as economic, education, social and community context, neighborhood, and the built environment. They include upstream factors such as political, socioeconomic, and cultural constructs, as well as place-based factors such as access to healthcare
HSR23-117: First-Line (1L) Systemic Therapy in Patients (pts) With Advanced Non–Small Cell Lung Cancer (aNSCLC) at Community Settings in the United States (US)
Stephen Liu, Pragya Rai, Yu-Han Kao, Diana Chirovsky, and Ana Nunes
CLO19-058: Live Music to Decrease Patient Anxiety During Chemotherapy Treatments
Crystal Weaver, Mark Varvares, Elaine Ottenlips, Kara Christopher, and Andrew Dwiggins
Background: Music therapy began in the United States after World War II when community musicians went to veterans’ hospitals to provide live music to those experiencing post-war trauma. Music therapy programs continue to utilize community musicians
Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple Myeloma
Ashley T. Freeman, May Kuo, Lei Zhou, Justin G. Trogdon, Chris D. Baggett, Sascha A. Tuchman, Thomas C. Shea, and William A. Wood
volume on patient outcomes may help inform referral practices. A common practice is to refer patients to an MM specialist for treatment recommendations, but to perform most care in the community. The impact on survival of patient-sharing among MM
HSR19-097: Understanding U.S. Mutational Testing Patterns and Treatment Implications in Gastrointestinal Stromal Tumors (GIST) Patients
Khalid Mamlouk, Zach Crouch, Philina Lee, Clive Mendonca, Maria Gumina, and Brian Rubin
treaters further examines mutational testing and treatment decisions to better understand current practices and educational needs. Methods: Hematologist/oncologists who practiced in academic or community settings were eligible if they treated ≥5 pts with
